Skip to main content

RETRACTION article

Front. Cell. Neurosci., 18 March 2022
Sec. Cellular Neuropathology
Volume 16 - 2022 | https://doi.org/10.3389/fncel.2022.882351
This article is part of the Research Topic Advances in CNS Repair, Regeneration, and Neuroplasticity: From Basic Mechanisms to Therapeutic Strategies View all 32 articles

Retraction: Allopregnanolone Modulates GABAAR-Dependent CaMKIIδ3 and BDNF to Protect SH-SY5Y Cells Against 6-OHDA-Induced Damage

This article is a retraction of:

  1. RETRACTED: Allopregnanolone Modulates GABAAR-Dependent CaMKIIδ3 and BDNF to Protect SH-SY5Y Cells Against 6-OHDA-Induced Damage

    1. Read original article
\nFrontiers Editorial Office Frontiers Editorial Office*

A Retraction of the Original Research Article
Allopregnanolone Modulates GABAAR-Dependent CaMKIIδ3 and BDNF to Protect SH-SY5Y Cells Against 6-OHDA-Induced Damage

by Wang, T., Ye, X., Bian, W., Chen, Z., Du, J., Li, M., Zhou, P., Cui, H., Ding, Y-Q., Qi, S., Liao, M., and Sun, C. (2020). Front. Cell. Neurosci. 13:569. doi: 10.3389/fncel.2019.00569

The journal retracts the 13 January 2020 article cited above.

Following publication, concerns were raised regarding the integrity of the data in the published figures. The authors failed to provide a satisfactory explanation during the investigation, which was conducted in accordance with Frontiers' policies.

This retraction was approved by the Chief Editors of Frontiers in Cellular Neuroscience and the Chief Executive Editor of Frontiers. The authors agree to this retraction.

Citation: Frontiers Editorial Office (2022) Retraction: Allopregnanolone Modulates GABAAR-Dependent CaMKIIδ3 and BDNF to Protect SH-SY5Y Cells Against 6-OHDA-Induced Damage. Front. Cell. Neurosci. 16:882351. doi: 10.3389/fncel.2022.882351

Received: 23 February 2022; Accepted: 23 February 2022;
Published: 18 March 2022.

Approved by:

Dirk M. Hermann, University of Duisburg-Essen, Germany

Copyright © 2022 Frontiers Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Frontiers Editorial Office, editorial.office@frontiersin.org

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.